Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction

性激素与肺血管和右心室功能障碍

基本信息

项目摘要

PROJECT SUMMARY (See instructions); Female sex is the best established risk factor for pulmonary arterial hypertension (PAH), yet women have preserved right ventricular (RV) function and survival compared to men with PAH. This so-called "estrogen paradox" is as yet unexplained. RV function determines outcome in disease, but the mechanisms and determinants of RV failure are unknown. We hypothesize that high estrogen states promote pulmonary vascular angiogenesis and RV myocardial collateral flow, resulting in pleiotropic effects on the pulmonary vasculature and the RV. In postmenopausal women, the hormonal mileu (e.g., sex hormone and estradiol [E2] metabolite levels) can be characterized; in premenopausal women the normal menstrual cycle (marked by a predictable spike in E2) provides a physiologic model to characterize these relationships. We propose: 1) a prospective cohort study (N=75) to determine whether the sex hormone milieu is associated with markers of angiogenesis (vascular endothelial growth factor [VEGF], angiopoietins [Ang], endothelial progenitor cells [EPCs]) and RV function assessed by hemodynamics in postmenopausal women wdth PAH and 2) a prospective case-control study (N = 40) to determine whether the menstrual cycle is associated with markers of angiogenesis (VEGF, Ang, EPCs) and RV function assessed by echocardiography in premenopausal women with PAH as compared to controls. We anticipate that in both pre and postmenopausal women, high E2 states will be associated with higher levels of angiogenesis markers but improved surrogates of RV function. The extent to which the influence of sex hormones on markers of angiogenesis and RV function can be defined is supported by 1) the use of separate studies to incorporate both pre and postmenopausal women and 2) the combination of a variety of carefully selected biomarkers aimed at both angiogenesis and RV function.
项目总结(参见说明); 女性是肺动脉高压(PAH)的最佳既定风险因素,但与PAH男性相比,女性保留了右心室(RV)功能和生存率。这种所谓的“雌激素悖论”至今仍无法解释。RV功能决定疾病的结局,但RV衰竭的机制和决定因素尚不清楚。我们假设高雌激素状态促进肺血管新生和右心室心肌侧支血流,导致对肺血管和右心室的多效性效应。在绝经后妇女中,激素环境(例如,性激素和雌二醇[E2]代谢物水平);在绝经前妇女中,正常月经周期(以E2的可预测峰值为标志)提供了表征这些关系的生理模型。我们建议:1)前瞻性队列研究(N=75),以确定性激素环境是否与血管生成标志物相关(血管内皮生长因子[VEGF]、血管生成素[Ang],内皮祖细胞[EPCs])和通过血流动力学评估的RV功能,以及2)一项前瞻性病例对照研究(N = 40)确定绝经前PAH女性与对照组相比,月经周期是否与血管生成标志物(VEGF、Ang、EPCs)和通过超声心动图评估的RV功能相关。我们预计,在绝经前和绝经后妇女,高E2状态将与较高水平的血管生成标志物,但改善替代RV功能。 性激素对血管生成和RV功能标志物的影响程度可以通过以下方式确定:1)使用单独的研究纳入绝经前和绝经后女性,2)结合各种精心选择的旨在血管生成和RV功能的生物标志物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corey E Ventetuolo其他文献

Corey E Ventetuolo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corey E Ventetuolo', 18)}}的其他基金

Effects of DHEA in Pulmonary Hypertension (DiPH)
DHEA 对肺动脉高压 (DiPH) 的影响
  • 批准号:
    10402875
  • 财政年份:
    2018
  • 资助金额:
    $ 26.07万
  • 项目类别:
Effects of DHEA in Pulmonary Hypertension (DiPH)
DHEA 对肺动脉高压 (DiPH) 的影响
  • 批准号:
    9923748
  • 财政年份:
    2018
  • 资助金额:
    $ 26.07万
  • 项目类别:
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
性激素与肺血管和右心室功能障碍
  • 批准号:
    8854115
  • 财政年份:
  • 资助金额:
    $ 26.07万
  • 项目类别:
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
性激素与肺血管和右心室功能障碍
  • 批准号:
    8465684
  • 财政年份:
  • 资助金额:
    $ 26.07万
  • 项目类别:
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
性激素与肺血管和右心室功能障碍
  • 批准号:
    9085127
  • 财政年份:
  • 资助金额:
    $ 26.07万
  • 项目类别:
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
性激素与肺血管和右心室功能障碍
  • 批准号:
    8735966
  • 财政年份:
  • 资助金额:
    $ 26.07万
  • 项目类别:

相似国自然基金

益肺清化颗粒对血管生成因子及VEGF/KDR和Angiopoietins /Tie2信号传导通路的调控作用研究
  • 批准号:
    30973841
  • 批准年份:
    2009
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
  • 批准号:
    10301502
  • 财政年份:
    2021
  • 资助金额:
    $ 26.07万
  • 项目类别:
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
  • 批准号:
    10487563
  • 财政年份:
    2021
  • 资助金额:
    $ 26.07万
  • 项目类别:
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
  • 批准号:
    10626144
  • 财政年份:
    2021
  • 资助金额:
    $ 26.07万
  • 项目类别:
Differential agonistic activities of angiopoietins on neutrophils
血管生成素对中性粒细胞的差异激动活性
  • 批准号:
    304873
  • 财政年份:
    2014
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Operating Grants
The Role of Angiopoietins 1 and 2 in ANCA Associated Vasculitis
血管生成素 1 和 2 在 ANCA 相关性血管炎中的作用
  • 批准号:
    MR/K000977/1
  • 财政年份:
    2013
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Fellowship
Expression and functional roles of angiopoietins in lymphangiogenesis and development of lymphatic induction system
血管生成素在淋巴管生成和淋巴诱导系统发育中的表达和功能作用
  • 批准号:
    21590217
  • 财政年份:
    2009
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Agonistic activities of angiopoietins on neutrophils
血管生成素对中性粒细胞的激动活性
  • 批准号:
    181135
  • 财政年份:
    2009
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Operating Grants
Elucidation of molecular mechanisms of angiogenesis mediated by angiopoietins and its application for asthma therapy
阐明血管生成素介导的血管生成的分子机制及其在哮喘治疗中的应用
  • 批准号:
    20590901
  • 财政年份:
    2008
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of skeletal muscle injury and regeneration by angiopoietins
血管生成素对骨骼肌损伤和再生的调节
  • 批准号:
    171081
  • 财政年份:
    2008
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Operating Grants
The Role of Tie2 and the Angiopoietins in EPC Biology
Tie2 和血管生成素在 EPC 生物学中的作用
  • 批准号:
    6999609
  • 财政年份:
    2005
  • 资助金额:
    $ 26.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了